ISD-Immunotech Press Releases - EIN Presswire - Press Release Distribution Service

Published on May 26, 2021 - 12:37 GMT

ISD Immunotech granted US and EU patents for novel severe systemic lupus erythematosus (SLE) therapy candidate ISD017

ISD Immunotech granted US and EU patents for ISD017 a first-in-class drug candidate in development for severe systemic lupus erythematosus (SLE) patients COPENHAGEN, DENMARK, May 26, 2021 /⁨EINPresswire.com⁩/ -- ISD Immunotech (“ISD”), a private …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on April 6, 2021 - 06:34 GMT

The STING pathway as a master key in autoimmune disease

ISD Immunotech Announces Scientific Publication Supporting Therapeutic Potential of its Lead Candidate ISD017 in Severe Lupus Patients COPENHAGEN, DENMARK, April 6, 2021 /⁨EINPresswire.com⁩/ -- ISD Immunotech, a preclinical stage biotechnology company …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 18, 2021 - 08:46 GMT

ISD Immunotech strengthens scientific advisory board

ISD Immunotech today announced that the company’s scientific advisory board gains new industry medical expertise through the appointment of Dr Harsukh Parmar. COPENHAGEN, DENMARK, March 18, 2021 /⁨EINPresswire.com⁩/ -- Dr. Harsukh Parmar has been …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...